Efficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials.
about
Lixisenatide as add-on therapy to basal insulinCommon standards of basal insulin titration in type 2 diabetesInitiation and Intensification Strategies in Type 2 Diabetes Management: A Comparison of Basal Plus and Premix RegimensEvidence-based clinical use of insulin premixturesDistinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes MellitusEvaluation of insulin regimens as an effective option for glycemic control in patients with type 2 diabetes: A propensity score-matched cohort study across Japan (JDDM31)Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trialEfficacy and safety of sitagliptin added to insulin in Japanese patients with type 2 diabetes: the EDIT randomized trial.Actionable self-monitoring of blood glucose: redefining the role for patients using multiple daily injection therapy.Results of glycated hemoglobin during treatment with insulin analogues dispensed in the public health system of Federal District in Brazil.Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 DiabetesBasal supplementation of insulin lispro protamine suspension versus insulin glargine and detemir for type 2 diabetes: meta-analysis of randomized controlled trialsLong-acting basal insulin analogs: latest developments and clinical usefulness.Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial.Patients' with type 2 diabetes willingness to pay for insulin therapy and clinical outcomesManagement of diabetes in Morocco: results of the International Diabetes Management Practices Study (IDMPS) - wave 5Intensification of insulin therapy for type 2 diabetic patients in primary care: basal-bolus regimen versus premix insulin analogs: when and for whom?Incidence and predictors of hypoglycemia in Japanese patients with type 2 diabetes treated by insulin glargine and oral antidiabetic drugs in real-life: ALOHA post-marketing surveillance study sub-analysisDeterminants of weight change in patients on basal insulin treatment: an analysis of the DIVE registry.Current insulin analogues in the treatment of diabetes: emphasis on type 2 diabetes.Humalog (lispro) for type 2 diabetes.Review of insulin-dependent and insulin-independent agents for treating patients with type 2 diabetes mellitus and potential role for sodium-glucose co-transporter 2 inhibitors.Is there evidence to support use of premixed or prandial insulin regimens in insulin-naive or previously insulin-treated type 2 diabetic patients?A comparison of biphasic insulin aspart and insulin glargine administered with oral antidiabetic drugs in type 2 diabetes mellitus--a systematic review and meta-analysis.Pharmacologic treatment of type 2 diabetes: injectable medications.Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.Recent development of single preparations and fixed-dose combination tablets for the treatment of non-insulin-dependent diabetes mellitus : A comprehensive summary for antidiabetic drugs.Basal Insulin Use With GLP-1 Receptor Agonists.Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies.Adherence to Insulin Therapy.Perceptions of diabetes control among people with type 2 diabetes treated with basal insulin in Sweden, Switzerland, and the United Kingdom.Effectiveness of intensification therapies in Danes with Type 2 diabetes who use basal insulin: a population-based study.Premixed insulin regimens in type 2 diabetes: pros.Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape).Safety and Effectiveness of Switching from a Basal-only to Biphasic Insulin Aspart 30 Insulin Regimen.Self-monitoring of blood glucose and type 2 diabetes: new tricks for the old dog?Improvement of β-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control.Randomized, 1-year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice-daily premixed insulin versus basal insulin with either basal-plus one prandial insulin or basal-bolus up to three prandial injections.Cost-Effectiveness of IDegLira Versus Insulin Intensification Regimens for the Treatment of Adults with Type 2 Diabetes in the Czech Republic.Cost-effectiveness analysis of IDegLira versus basal-bolus insulin for patients with type 2 diabetes in the Slovak health system.
P2860
Q27007547-74047D03-B083-4560-BFF6-B63B43BF304EQ27009355-D506750D-AAD2-4A65-AAF7-7BD744E256AEQ28077688-F070B3D2-B141-43F0-82EB-83F243B0F55FQ33591271-DBB0730A-C622-4EDB-90EF-ED505549CA0DQ33785190-D934FE59-82D2-4D11-A124-A31D4FA30F7AQ34299641-3E531D6D-4AB3-4972-8EF6-DC70FC472CB9Q34543042-D006A3DD-B6C9-4FE5-BE51-AB7E642197E3Q35225372-4FF0F517-E467-4901-9418-F9D58C0A8CCBQ35685013-2A303EFD-7D66-4B98-9C9D-244BD820D344Q35964744-D912E1CA-B80A-4578-A355-46E7D94CEF76Q36073434-9DC7F7DC-E6CE-465E-B843-2B844D9D06EEQ36426817-2EA34A63-CD5F-4677-B345-DBE4C80F6C7FQ36515474-76AE9F1D-A1C9-4074-8CF1-935A487DC213Q36633079-2AE38A17-E520-463F-ACF9-2DC5E2D48FAFQ36860522-2D7A8E69-50F1-43B0-96D7-1C0F57C780CDQ36967167-132EA0DF-B462-43E8-A3E5-21BD418B53ADQ37577153-5977CC89-7134-4D04-AA68-D8778AFA1937Q37597568-90E8A547-6421-4E12-AC82-5B515A01562FQ37612059-BD70C93A-4AC0-4735-B382-C882290CD0DEQ37972941-6012825A-A453-4A81-80BD-80B50573EC64Q38050151-B2BD0288-0091-4CAD-9F3B-9601BF7AD074Q38113101-920BF03E-34DA-465E-9ED6-1A47E1D4B291Q38123793-EB320368-DFC7-4959-A99F-5FD41A940C04Q38182669-58D1B70D-A7D0-458F-860C-55651AAC96A5Q38388602-01F08C8E-3163-4092-927E-131D67F18D17Q38568342-C042D326-1F8C-4113-9214-CE0ED1DEB8A7Q38845574-2F7AF29E-DD49-4FF8-A530-2F2248646A73Q38940711-359D7175-4EFB-43C6-AAEC-8181D1D0DCBAQ39350860-8275262B-9378-4F4A-B87D-8590965075F3Q39441628-B5789CA0-84B6-4652-A1FC-B824600C641BQ39708796-9AA41C5A-07F9-4C46-B53C-6CEFF310D44BQ40711181-F26C4368-0CD0-4A05-B27D-D6D90146CB9FQ40839083-B779990C-3480-4640-BE9C-7C651E775B45Q41661396-4E6BBC8A-3555-4D2B-9823-C17D10979BEEQ41867228-1ECD2C7C-47DC-460B-861F-2A6900D96FB5Q42779154-4997C2D6-6CC5-4BE8-9E01-D818F6D6BF4CQ44598061-BA3BD85E-ACE4-4BCF-BD55-E21DCF05FBD7Q46094723-84D6FC10-4B24-4721-9C5A-54B5721F4C54Q47117737-E3EFF063-70AD-471A-96BD-CB1FD2068261Q47136443-34A02B17-2092-4BF1-8D68-6F5C2148166F
P2860
Efficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Efficacy of insulin analogs in ...... randomized controlled trials.
@ast
Efficacy of insulin analogs in ...... randomized controlled trials.
@en
Efficacy of insulin analogs in ...... randomized controlled trials.
@nl
type
label
Efficacy of insulin analogs in ...... randomized controlled trials.
@ast
Efficacy of insulin analogs in ...... randomized controlled trials.
@en
Efficacy of insulin analogs in ...... randomized controlled trials.
@nl
prefLabel
Efficacy of insulin analogs in ...... randomized controlled trials.
@ast
Efficacy of insulin analogs in ...... randomized controlled trials.
@en
Efficacy of insulin analogs in ...... randomized controlled trials.
@nl
P2860
P50
P921
P356
P1433
P1476
Efficacy of insulin analogs in ...... randomized controlled trials.
@en
P2093
Giuseppe Bellastella
Katherine Esposito
P2860
P304
P356
10.2337/DC10-1710
P407
P577
2011-01-07T00:00:00Z